- API
Social Vulnerability Index 2018 - United States, county
data.cdc.gov | Last Updated 2022-02-14T14:19:58.000ZATSDR’s Geospatial Research, Analysis & Services Program (GRASP) created Centers for Disease Control and Prevention Social Vulnerability Index (CDC SVI or simply SVI, hereafter) to help public health officials and emergency response planners identify and map the communities that will most likely need support before, during, and after a hazardous event. SVI indicates the relative vulnerability of every U.S. Census tract. Census tracts are subdivisions of counties for which the Census collects statistical data. SVI ranks the tracts on 15 social factors, including unemployment, minority status, and disability, and further groups them into four related themes. Thus, each tract receives a ranking for each Census variable and for each of the four themes, as well as an overall ranking. In addition to tract-level rankings, SVI 2018 also has corresponding rankings at the county level. Notes below that describe “tract” methods also refer to county methods.
- API
NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human
data.cdc.gov | Last Updated 2019-05-30T22:48:59.000ZNNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. Note: This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. Footnotes: U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases — The reporting jurisdiction did not submit any cases to CDC. N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable — This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized. Cum: Cumulative year-to-date counts. Max: Maximum — Maximum case count during the previous 52 weeks. * Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
- API
NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human
data.cdc.gov | Last Updated 2021-01-07T19:21:30.000ZNNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human - 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. Note: This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. Footnotes: U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases — The reporting jurisdiction did not submit any cases to CDC. N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable — This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published. NC: Not calculated — There is insufficient data available to support the calculation of this statistic. Cum: Cumulative year-to-date counts. Max: Maximum — Maximum case count during the previous 52 weeks. * Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
- API
Botswana Combination Prevention Project (BCPP) - Public Release Data
data.cdc.gov | Last Updated 2022-05-24T12:45:57.000ZThe Botswana Combination Prevention Project (BCPP) was a research project conducted by the Botswana Ministry of Health (MOH), Harvard School of Public Health/Botswana Harvard AIDS Institute Partnership (BHP), and the U.S. Centers for Disease Control and Prevention (CDC). BCPP was a community randomized trial that examined the impact of prevention interventions on HIV incidence in 15 intervention and 15 control communities. The interventions included extensive HIV testing, linkage to care, and universal treatment services. To reduce HIV incidence in the intervention communities, the UNAIDS 90-90-90 goals were used: 90% of HIV-positive persons know their status; 90% of persons who know status are to be on ART; 90% of persons on ART are to be virally suppressed. The BCPP study is composed of 2 interlocking protocols: Evaluation Protocol and Intervention Protocol. The Evaluation Protocol of the BCPP evaluated the primary endpoint (HIV incidence), as well as some key related secondary endpoints. This protocol focused on the Baseline Household Survey; the HIV Incidence Cohort; and an End of Study Survey. The Intervention Protocol of the BCPP implemented the combination prevention (CP) intervention package in CPCs and measures the uptake of these interventions (expanded HIV testing and counselling, strengthened male circumcision, and expanded HIV Care and Treatment).
- API
NNDSS - Table II. Mumps to Rabies, animal
data.cdc.gov | Last Updated 2015-08-27T22:44:46.000ZNNDSS - Table II. Mumps to Rabies, animal - 2014.In this Table, all conditions with a 5-year average annual national total of more than or equals 1,000 cases but less than or equals 10,000 cases will be displayed (��� 1,000 and ��_ 10,000). The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data. Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable. -: No reported cases. N: Not reportable. NN: Not Nationally Notifiable Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. * Case counts for reporting years 2013 and 2014 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly.More information on NNDSS is available at http://wwwn.cdc.gov/nndss/.
- API
NNDSS - Table II. Mumps to Rabies, animal
data.cdc.gov | Last Updated 2016-01-07T15:52:24.000ZNNDSS - Table II. Mumps to Rabies, animal - 2015.In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed.The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data. Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable. -: No reported cases. N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. * Three low incidence conditions, rubella, rubella congenital, and tetanus, have been moved to Table 2 to facilitate case count verification with reporting jurisdictions. ��� Case counts for reporting year 2015 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly.
- API
Healthy People 2020 Final Progress Table
data.cdc.gov | Last Updated 2023-08-23T19:39:25.000Z[1] Status is determined using the baseline, final, and target value. The statuses used in Healthy People 2020 were: 1 - Target met or exceeded—One of the following applies: (i) At baseline, the target was not met or exceeded, and the most recent value was equal to or exceeded the target. (The percentage of targeted change achieved was equal to or greater than 100%.); (ii) The baseline and most recent values were equal to or exceeded the target. (The percentage of targeted change achieved was not assessed.) 2 - Improved—One of the following applies: (i) Movement was toward the target, standard errors were available, and the percentage of targeted change achieved was statistically significant; (ii) Movement was toward the target, standard errors were not available, and the objective had achieved 10% or more of the targeted change. 3 - Little or no detectable change—One of the following applies: (i) Movement was toward the target, standard errors were available, and the percentage of targeted change achieved was not statistically significant; (ii) Movement was toward the target, standard errors were not available, and the objective had achieved less than 10% of the targeted change; (iii) Movement was away from the baseline and target, standard errors were available, and the percent change relative to the baseline was not statistically significant; (iv) Movement was away from the baseline and target, standard errors were not available, and the objective had moved less than 10% relative to the baseline; (v) No change was observed between the baseline and the final data point. 4 - Got worse—One of the following applies: (i) Movement was away from the baseline and target, standard errors were available, and the percent change relative to the baseline was statistically significant; (ii) Movement was away from the baseline and target, standard errors were not available, and the objective had moved 10% or more relative to the baseline. 5 - Baseline only—The objective only had one data point, so progress toward target attainment could not be assessed. Note that if additional data points did not meet the criteria for statistical reliability, data quality, or confidentiality, the objective was categorized as baseline only. 6 - Informational—A target was not set for this objective, so progress toward target attainment could not be assessed. [2] The final value is generally based on data available on the Healthy People 2020 website as of January 2020. For objectives that are continuing into Healthy People 2030, more recent data are available on the Healthy People 2030 website: https://health.gov/healthypeople. [3] For objectives that moved toward their targets, movement toward the target was measured as the percentage of targeted change achieved (unless the target was already met or exceeded at baseline): Percentage of targeted change achieved = (Final value - Baseline value) / (HP2020 target - Baseline value) * 100 [4] For objectives that were not improving, did not meet or exceed their targets, and did not move towards their targets, movement away from the baseline was measured as the magnitude of the percent change from baseline: Magnitude of percent change from baseline = |Final value - Baseline value| / Baseline value * 100 [5] Statistical significance was tested when the objective had a target, at least two data points (of unequal value), and available standard errors of the data. A normal distribution was assumed. All available digits were used to test statistical significance. Statistical significance of the percentage of targeted change achieved or the magnitude of the percentage change from baseline was assessed at the 0.05 level using a normal one-sided test. [6] For more information on the Healthy People 2020 methodology for measuring progress toward target attainment and the elimination of health disparities, see: Healthy People Statistical Notes, no 27; available from: https://www.cdc.gov/nchs/data/sta
- API
Influenza Vaccination Coverage for All Ages (6+ Months)
data.cdc.gov | Last Updated 2023-09-28T16:08:58.000ZInfluenza Vaccination Coverage for All Ages (6+ Months) • Data on influenza vaccination coverage from the National Immunization Survey-Flu (NIS-Flu) and the Behavioral Risk Factor Surveillance System (BRFSS) for the general population at the national, regional, and state levels by age group and race/ethnicity. • Additional information available at https://www.cdc.gov/flu/fluvaxview/index.htm
- API
Air Quality Measures on the National Environmental Health Tracking Network
data.cdc.gov | Last Updated 2018-06-05T13:04:35.000ZThe Environmental Protection Agency (EPA) provides air pollution data about ozone and particulate matter (PM2.5) to CDC for the Tracking Network. The EPA maintains a database called the Air Quality System (AQS) which contains data from approximately 4,000 monitoring stations around the country, mainly in urban areas. Data from the AQS is considered the "gold standard" for determining outdoor air pollution. However, AQS data are limited because the monitoring stations are usually in urban areas or cities and because they only take air samples for some air pollutants every three days or during times of the year when air pollution is very high. CDC and EPA have worked together to develop a statistical model (Downscaler) to make modeled predictions available for environmental public health tracking purposes in areas of the country that do not have monitors and to fill in the time gaps when monitors may not be recording data. This data does not include "Percent of population in counties exceeding NAAQS (vs. population in counties that either meet the standard or do not monitor PM2.5)". Please visit the Tracking homepage for this information.View additional information for indicator definitions and documentation by selecting Content Area "Air Quality" and the respective indicator at the following website: http://ephtracking.cdc.gov/showIndicatorsData.action